Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection.

This case report describes a case of chronic Epstein-Barr virus infection resulting in lymphadenopathy morphologically indistinguishable from Hodgkin's disease. Morphologic, immunologic, and virologic studies could be performed on three consecutive lymph nodes. For the first time in the literature, Epstein-Barr Nuclear Antigen (EBNA) could be demonstrated in the nuclei of Sternberg-Reed cells.

[1]  S. Poppema,et al.  Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B‐cell origin of sternberg‐reed cells , 1985, Cancer.

[2]  H. Zola,et al.  The reactivity of Reed–Sternberg cells with monoclonal antisera at thin section and ultrastructural levels , 1983, The Journal of pathology.

[3]  E. Reinherz,et al.  Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. , 1983, Journal of immunology.

[4]  R. Veltri,et al.  Epstein‐barr virus, fatal infectious mononucleosis, and Hodgkin's disease in siblings , 1983, Cancer.

[5]  R. Penny,et al.  Cell-mediated immune deficiency in Hodgkin's disease. , 1982, Immunology today.

[6]  E. Reinherz,et al.  Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Purtilo,et al.  Malignant lymphoproliferative diseases induced by Epstein-Barr Virus in immunodeficient patients, including X-linked, cytogenetic, and familial syndromes. , 1981, Cancer genetics and cytogenetics.

[8]  A. Evans,et al.  PRESENCE OF ELEVATED ANTIBODY TITRES TO EPSTEIN-BARR VIRUS BEFORE HODGKIN'S DISEASE , 1981, The Lancet.

[9]  E. Reinherz,et al.  Distribution of T cell subsets in human lymph nodes , 1981, The Journal of experimental medicine.

[10]  S. D. Patterson,et al.  Nasal blastoma: a light and electron microscopic study. , 1980, Ultrastructural pathology.

[11]  D. Purtilo.  EPSTEIN-BARR-VIRUS-INDUCED ONCOGENESIS IN IMMUNE-DEFICIENT INDIVIDUALS , 1980, The Lancet.

[12]  G. Kvåle,et al.  Hodgkin's disease in patients with previous infectious mononucleosis , 1979, International journal of cancer.

[13]  J. Smit,et al.  LYMPHOCYTE SUB-POPULATIONS IN LYMPHOPROLIFERATIVE DISEASES - PARALLEL TUBULAR STRUCTURES IN FC RECEPTOR-BEARING LYMPHOCYTES , 1979 .

[14]  J. Kersey,et al.  Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency--cancer registry. , 1978, Clinical immunology and immunopathology.

[15]  G. Klein,et al.  Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.

[16]  W. Henle,et al.  Epstein-Barr virus-related serology in Hodgkin's disease. , 1973, National Cancer Institute monograph.